CUSIP H17182108NAMEN AKTCRSPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
471 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ark Investment Management LLC | 10.52M | $551.78M | +735.1K | Added |
| 2 | Blackrock, Inc. | 7.51M | $393.73M | +458.0K | Added |
| 3 | Orbis Allan Gray Ltd | 5.95M | $312.03M | +968.1K | Added |
| 4 | Capital International Investors | 5.89M | $309.02M |
| +243.5K |
| Added |
| 5 | State Street Corp | 3.75M | $196.83M | −253.8K | Reduced |
| 6 | Gsk PLC | 3.22M | $168.89M | +3.22M | New Position |
| 7 | Ubs Group AG | 2.52M | $132.37M | +185.1K | Added |
| 8 | Vanguard Group Inc | 2.27M | $118.95M | −96.3K | Reduced |
| 9 | Geode Capital Management, LLC | 2.25M | $117.97M | +108.1K | Added |
| 10 | Sr One Capital Management, LP | 2.04M | $106.91M | 0 | Held |
See every fund holding Crispr Therapeutics AG, with full quarter-over-quarter share changes.
Unlock all holders